Stay updated on Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision tag Revision: v3.5.4 was added and the previous Revision: v3.5.3 was removed, indicating an update to the page's version metadata.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page’s footer/version indicator was updated from Revision v3.5.2 to v3.5.3. Additional non-core resource labeling (e.g., a genetics/rare diseases resource entry and “Idiopathic Pulmonary Fibrosis” resource section) was added/clarified.SummaryDifference0.3%

- Check39 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved references to Interstitial lung disease 2 and the Genetic and Rare Diseases Information Center under Resources.SummaryDifference0.2%

- Check68 days agoChange Detected- Revision updated to v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

- Check75 days agoChange DetectedFooter now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.